metricas
covid
Buscar en
Open Respiratory Archives
Toda la web
Inicio Open Respiratory Archives Bacterial Superinfection in COVID-19 Patients Diagnosed With Dual-Energy CT Pulm...
Journal Information
Vol. 2. Issue 4.
Pages 295 (October - December 2020)
Share
Share
Download PDF
More article options
Vol. 2. Issue 4.
Pages 295 (October - December 2020)
Clinical image
Open Access
Bacterial Superinfection in COVID-19 Patients Diagnosed With Dual-Energy CT Pulmonary Angiography
Sobreinfección bacteriana en pacientes con COVID-19 diagnosticada mediante angiografíapulmonar realizada con TC de energía dual
Visits
5887
Salvatore Marsicoa,
Corresponding author
40161@parcdesalutmar.cat

Corresponding author.
, Santiago Javier Carbullanca Toledoa, Flavio Zuccarinoa,b
a Department of Radiology, Hospital del Mar, Barcelona, Spain
b Department of Radiology, Hospital Sant Joan de Deu, Esplugues de Llobregat, Barcelona, Spain
This item has received

Under a Creative Commons license
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Full Text

A 89-year-old woman presenting with dry cough and fever. COVID-19 pneumonia was confirmed by RT-PCR test and Chest X-ray (Fig. 1A).

Fig. 1.

(A) Chest X-ray with single anteroposterior projection, performed the admission day, showed bilateral diffuse opacities secondary to COVID-19 pneumonia (white arrows). (B) Transverse CT images with lung window shows multiples diffuse parenchymal ground glass opacities and consolidations, typical of COVID-19 pneumonia (blue arrows). (C) Transverse CT images with mediastinal window shows posterior bilateral pleural effusion (red arrows) and bilateral heterogeneous lung consolidations (white arrows). Left central consolidation shows low contrast uptake (yellow arrow). (D) Iodine map images confirmed a central area of decreased perfusion (yellow arrow) in the left superior lobe, compatible with pulmonary superinfection confirmed later with bronchoalveolar lavage (Pseudomonas Aeruginosa).

(0.16MB).

During the hospitalization the patient showed a progressive respiratory worsening, fever and dyspnoea. On the 14th day of hospitalization a CT pulmonary angiography (CTPA) was performed. CT showed the presence of multiple bilaterally ground glass opacities secondary to COVID-19 pneumonia (1B). We also observed atypical CT findings such as bilateral pleural effusion and a central left hypodense consolidation, affecting the left upper lobe and the superior lingula, suspected of bacterial superinfection (Fig. 1C). A subsequent Bronchoalveolar lavage (BAL) confirmed a bacterial superinfection by Pseudomonas Aeruginosa.

Bacterial superinfection concomitant to COVID-19 infection has been scarcely and irregularly reported (3.2–15%) in different case series of COVID-19 published to date.1,2

Central or lobar consolidations with hipoperfusion evidenced by dual energy CT pulmonary angiography, associated with centrilobular nodules, represent CT findings suspected of superinfection.

As we know this is the first report that included dual-energy CT pulmonary angiography features description.

It is essential to recognize atypical CT patterns in COVID-19 patients to quickly suggest superinfection that represents a frequent and treatable complication.

References
[1]
S. Hughes, O. Troise, H. Donaldson, N. Mughal, L.S.P. Moore.
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting [published online ahead of print, 2020 Jun 27].
Clin Microbiol Infect, (2020),
[2]
Q. Ruan, K. Yang, W. Wang, L. Jiang, J. Song.
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan China [published correction appears in Intensive Care Med. 2020 Apr 6].
Intensive Care Med, 46 (2020), pp. 846-848
Copyright © 2020. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.opresp.2022.100215
No mostrar más